NCT03874078 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Dewar R, Claus AP, Tucker K, Ware R, Johnston LM
Reproducibility of the Balance Evaluation Systems Test (BESTest) and the Mini-BESTest in school-aged children. Gait Posture. 2017 Jun;55:68-74. doi: 10.1016/j.gaitpost.2017.04.010. Epub 2017 Apr 6.
Dewar R, Claus AP, Tucker K, Ware RS, Johnston LM
Reproducibility of the Kids-BESTest and the Kids-Mini-BESTest for Children With Cerebral Palsy. Arch Phys Med Rehabil. 2019 Apr;100(4):695-702. doi: 10.1016/j.apmr.2018.12.021. Epub 2019 Jan 9.
Horak FB, Wrisley DM, Frank J
The Balance Evaluation Systems Test (BESTest) to differentiate balance deficits. Phys Ther. 2009 May;89(5):484-98. doi: 10.2522/ptj.20080071. Epub 2009 Mar 27.

Turkish Version of Kids-BESTest (Balance Evaluation Systems Test) and Kids-Mini-BESTest, Validity and Reliability for School-Aged Children

Clinical trial NCT03874078 - References